Multidrug Treatment of Type 2 Diabetes
Year: 2011
Type: article
Abstract: Type 2 diabetes is a chronic and pro-gressive condition associated withthe risk of invalidating micro- and macrovascular complications. Hypergly-cemia is the hallmark of the condition and, despite much discussion, glycemic control remains a main goal of treatment in the attempt to prevent chronic com-plications. A beneficial effect of glycemic control was initially supported by the UK Di-abetes Prospective Study showing that intensive treatment, compared with con-ventional therapy, resulted in an average HbA1c level of 7 % and was associated with a 24 % relative risk reduction of any diabetes-related end point and a 37 % re-duction in the risk of microvascular dis-ease. Moreover, a nonsignificant 16% reduction (P = 0.052) in the risk of acute myocardial infarction was reported (1). Similar results were confirmed in the Kumamoto study (2), whereas the results of more recent intervention trials remain
Source: Diabetes Care
DOI: 10.2337/dc11-s235
Institution: University of Pisa
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W1989325640
